Repository landing page
IFNγ ELISpot assay on splenocytes of mice vaccinated two times with TMV-DOST vaccine.
Abstract
<p>Splenocytes were isolated from 2 mice per group on D65 after intranasal vaccination and incubated on IFNγ antibody coated plates at a final concentration of 10<sup>5</sup> cells/well. Whole protein antigen stimulants were added at 20 μg/mL, and plates incubated at 37°C in a 5% CO<sub>2</sub>, 99% humidity incubator for ~36h. IFNγ secreting cells were detected and developed using Mouse IFNγELISpot Ready-SET-Go! Kit, developed with AEC, and read on an AID ELISpot plate reader. IFNγ secretion from spleen cells stimulated with DnaK (<b>A</b>.) OmpA (<b>B.</b>) SucB (<b>C.</b>) and Tul4 (<b>D</b>.) are compared to no stimulation (no stim), or PBS vaccinated mice (Norm). Values were adjusted positive IFNγ spots per 10<sup>6</sup> cells, and groups that show significant augmentation with adjuvants compared to no adjuvant are shown (*p<0.05, **p<0.001). Means are presented ± standard deviation, and p values were calculated by non-parametric t-test. Results are representative of two experiments.</p- Image
- Figure
- Medicine
- Microbiology
- Biotechnology
- Immunology
- Cancer
- Infectious Diseases
- Biological Sciences not elsewhere classified
- Chemical Sciences not elsewhere classified
- TMV-DOST mixture
- isotype profile
- vaccine potency
- two-dose survival
- multi-antigen subunit vaccine
- tetravalent vaccine
- IgG 2 response
- Tobacco Mosaic virus
- subunit vaccines
- tularensis LVS challenge model
- Tul 4
- protection
- vaccine strain
- tularensis SchuS 4 proteins DnaK
- pathogen challenge
- mucosal immunity
- biothreat agent
- Francisella tularensis
- TMV-DOT
- antigen combination
- Gram-negative encapsulated coccobacillus bacterium
- Francisella tularensis LVS challenge Tularemia
- CDC lists F
- Previous vaccine studies
- two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine
- Intranasal administration
- antigen carrier
- Immune responses